A Study to Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
Clinical trial NCT07704892 · RECRUITING
Trial details
- NCT number
- NCT07704892
- Sponsor
- GlaxoSmithKline
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-22
- Primary completion
- 2030-10-16
- Enrollment
- 380
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.